Recap: Esperion Therapeutics Q4 Earnings

Esperion Therapeutics ESPR reported its Q4 earnings results on Tuesday, February 22, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Esperion Therapeutics beat estimated earnings by 22.03%, reporting an EPS of $-1.77 versus an estimate of $-2.27.

Revenue was up $5.76 million from the same period last year.

Last quarter the company beat on EPS by $0.17 which was followed by a 3.3% increase in the share price the next day.

Here's a look at Esperion Therapeutics's past performance:

Quarter	Q3 2021	Q2 2021	Q1 2021	Q4 2020
EPS Estimate	-2.79	-1.84	-2.52	-3.76
EPS Actual	-2.62	-1.67	-3.50	-3.89
Revenue Estimate	12.85M	42.27M	26.12M	12.52M
Revenue Actual	14.41M	40.66M	7.98M	9.64M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar